1,162.83 USD
↗ 47.15 (4.23%)LIVE (AS OF 12:39 PM EDT)
Shares of Eli Lilly & Co. (LLY) are trading at $1,162.83. LLY shows a split signal: underlying fundamentals suggest "Buy" while technical indicators indicate "Sell". This is driven by a robust Altman Z-Score, exceptional Return on Equity (81.0%) and a bullish Golden Cross on the moving averages. On the valuation front, LLY trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Aug 4, 2026.
Open?$1,174.00
High?$1,214.72
Low?$1,126.52
Prev. Close?$1,115.68
Volume?3.4M
Avg. Volume?2.8M
VWAP?$1,169.14
Rel. Volume?1.21x
Bid / Ask
Bid?$1,163.23 × 80
Ask?$1,164.98 × 80
Spread?$1.75
Midpoint?$1,164.11
Valuation & Ratios
Market Cap?994.9B
Shares Out?941.7M
Float?848.8M
Float %?90.1%
P/E Ratio?39.36
P/B Ratio?31.89
EPS?$28.35
Dividend?0.56%
Ex-Dividend?2026-08-14
News
Profile
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Themes
Employees
50.0K
Market Cap
1000.0B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
1970-07-09
Address
LILLY CORPORATE CTR
INDIANAPOLIS, IN 46285
Phone: (317) 276-2000
INDIANAPOLIS, IN 46285
Phone: (317) 276-2000
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?77
Z-Score?100
Momentum?83
Short Sent.?52
Piotroski F-Score?6/9Mixed
Altman Z-Score?9.05Safe
Confidence?71%Moderate
Short InterestModerate
Short % of Float?1.21%Low
Short Interest?10.3M
Days to Cover?4.1
Free Float848.8M
Avg Daily Volume2.5M
Settlement Date2026-07-15
Financial Health
Current Ratio?1.50Adequate
Quick Ratio?1.10Adequate
Cash Ratio?0.14Low
Debt/Equity?1.39Moderate
ValuationRICHLY VALUEDvs 10 peers + S&P 500
Score33/100
P/E?39.4PRICEY▾
Peers20
S&P18
P/B?31.89HIGH▾
Peers10
S&P3
P/S?13.77HIGH▾
Peers20
S&P3
P/FCF?84.2PRICEY▾
Peers10
S&P3
EV/EBITDA?28.5HIGH▾
Peers20
S&P11
EV/Sales?14.30HIGH▾
Peers20
S&P3
Returns & Efficiency
ROE?81.0%STRONG▾
Peers78
S&P97
ROA?21.7%STRONG▾
Peers90
S&P97
Cash Flow & Enterprise
FCF?$11.8B
Enterprise Value?$1033.0B
Fundamentals ratios updated end of day